ELDN SCHEDULE 13G/A: SEC filing
Biotechnology Value Fund and affiliated entities
Filed with the SEC on · accession 0000921895-26-003175
ELDN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 9.99% of Eledon Pharmaceuticals' common stock as of September 30, 2026, held through common shares, convertible preferred stock, pre-funded warrants, and Tranche A… The stock moved -6.9% by the first close after the filing.
Summary of the filing
Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 9.99% of Eledon Pharmaceuticals' common stock as of September 30, 2026, held through common shares, convertible preferred stock, pre-funded warrants, and Tranche A warrants, subject to 9.99% blocker provisions.
Key details
How ELDN stock reacted
Close before
$2.12
Nov 13, 2026
First close after
-6.86%
$1.97
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ELDN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ELDN?
Click hereFrequently asked questions
What did ELDN file with the SEC on Nov 16, 2026?
ELDN filed a SCHEDULE 13G/A (SEC filing). Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 9.99% of Eledon Pharmaceuticals' common stock as of September 30, 2026, held through common shares, convertible preferred stock, pre-funded warrants, and Tranche A warrants, subject to 9.99% blocker provisions.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ELDN stock react to this filing?
ELDN closed at $2.12 before the filing and $1.97 on Nov 16, 2026 (-6.86%).
Other ELDN SEC filings
- 8-K · SEC filingNov 12, 2026
- 10-Q · SEC filingNov 12, 2026
- SCHEDULE 13G/A · SEC filingOct 30, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · SEC filingJun 22, 2026
- 10-Q · SEC filingMay 13, 2026
- 8-K · SEC filingMay 13, 2026
- S-3 · Shelf registrationMay 1, 2026
- DEF 14A · Board changeApr 30, 2026
Get alerts when ELDN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days